The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A study of vistusertib in combination with selumetinib in patients with advanced cancers: TORCMEK phase Ib results.
 
Peter Schmid
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca; Bayer; Boehringer Ingelheim; Celgene; Eisai; Genentech/Roche (I); Merck; Novartis; Pfizer; Puma Biotechnology
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Genentech (Inst); Medivation (Inst); Novartis (Inst); Oncogenex (Inst)
 
Martin David Forster
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Lilly; Merck; Novartis; Pfizer
Travel, Accommodations, Expenses - Lilly; Merck; MSD Oncology; Pfizer; Roche
 
Yvonne J. Summers
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD
Travel, Accommodations, Expenses - Boehringer Ingelheim; MSD
 
Jane Good
No Relationships to Disclose
 
Shah-Jalal Sarker
No Relationships to Disclose
 
Louise Lim
No Relationships to Disclose
 
Kelly Mousa
No Relationships to Disclose
 
Gary William Middleton
Stock and Other Ownership Interests - Agenus
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Innovo; Lilly; MSD
Speakers' Bureau - BMS Brazil; Lilly; MSD
Research Funding - Alexion Pharmaceuticals; AstraZeneca; GemVax & KAEL
Travel, Accommodations, Expenses - MSD